Does losing weight by taking GLP-1 drugs such as Ozempic and Wegovy actually improve your risk of other diseases associated with obesity? New research led by scientists at the University of Liverpool in the UK, and presented at the European Congress on Obesity (ECO 2026), could have an answer. GLP-1 drugs are named after the glucagon-like peptide-1 hormone that they mimic, which helps suppress appetite , regulate insulin and blood sugar, and slow digestion. Newer medications in this category